-
公开(公告)号：US20240148893A1
公开(公告)日：2024-05-09
申请号：US18178854
申请日：2023-03-06
发明人： Yasuhiro MATSUMURA , Masahiro Yasunaga , Shinji Saijou , Shingo Hanaoka , Takahiro Anzai , Shino Manabe
IPC分类号： A61K47/68 , A61K39/395 , A61K49/00 , A61P35/00 , C07K16/30 , C12N5/10 , C12N15/09 , C12N15/62 , G01N33/574
CPC分类号： A61K47/6851 , A61K39/395 , A61K49/00 , A61P35/00 , C07K16/30 , C12N5/10 , C12N15/09 , C12N15/62 , G01N33/574 , G01N33/57419
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
公开(公告)号：US11633499B2
公开(公告)日：2023-04-25
申请号：US16083077
申请日：2017-03-07
发明人： Yasuhiro Matsumura , Masahiro Yasunaga , Shinji Saijou , Shingo Hanaoka , Takahiro Anzai , Shino Manabe
IPC分类号： G01N33/574 , C07K16/30 , A61K47/68 , C12N15/09 , C12N5/10 , A61K39/395 , A61K49/00 , A61P35/00 , C12N15/62
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
公开(公告)号：US20200078458A1
公开(公告)日：2020-03-12
申请号：US16578861
申请日：2019-09-23
IPC分类号： A61K39/395 , G01N33/574 , C07K16/30 , A61K39/00 , C07K16/18
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
4.发明授权公开(公告)号：US11524074B2
公开(公告)日：2022-12-13
申请号：US16578861
申请日：2019-09-23
IPC分类号： A61K39/395 , C07K16/30 , C07K16/18 , G01N33/574 , A61K39/00
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
公开(公告)号：US10471146B2
公开(公告)日：2019-11-12
申请号：US15509269
申请日：2015-09-08
IPC分类号： A61K39/395 , G01N33/577 , C07K16/30 , C12N15/13 , C07K16/18 , G01N33/574 , A61K39/00
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
公开(公告)号：US20170260284A1
公开(公告)日：2017-09-14
申请号：US15509269
申请日：2015-09-08
IPC分类号： C07K16/30 , A61K39/00 , G01N33/574 , A61K39/395
摘要： An object of the present invention is to provide an anticancer drug capable of treating cancer by finding a target molecule specifically expressed in cancer cells and by specifically acting on the target molecule, and to provide a cancer testing method including a step of measuring the target molecule in a sample. The present invention provides an anticancer drug containing, as an active ingredient thereof, an anti-transmembrane protein 180 (TMEM-180) antibody or an antigen-binding fragment thereof. In addition, the present invention provides a cancer testing method including a step of measuring the amount of TMEM-180 in a sample collected from a subject.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.023 秒)
